H1 and Q2 2024 Financial Results
We’ve announced our H1 and Q2 results, with the strength of our underlying business providing confidence to upgrade our full-year 2024 guidance. Total Revenue and Core EPS are now anticipated to grow by a mid teens percentage at CER.
Thank you to the AstraZeneca team around the world who continue to unlock the power of what science can do for people, society and the planet.
#AZN #whatsciencecando
------------------------------------------------------------
Global site: https://www.astrazeneca.com/
Careers site: https://careers.astrazeneca.com/
Follow us:
Twitter: / astrazeneca
LinkedIn: / astrazeneca
Instagram: / astrazeneca
Facebook: / astrazeneca